The JBRF has isolated and defined the Fear of Harm BPD phenotype, the first psychiatric illness to be associated with a heritable, physical biomarker. Click to view info graphic.
DetailsThis landmark study codifies years of clinical experience with intranasal ketamine which goes beyond the current research base to provide preliminary evidence of efficacy and safety over an extended period.
DetailsClinical experience using intranasal ketamine in the longitudinal treatment of juvenile bipolar disorder with fear of harm phenotype. Papolos D1, Frei M2, Rossignol D3, Mattis S4, Hernandez-Garcia LC5, Teicher MH5.J Affect Disord. 2017 Aug 30. 1. Were you surprised by your findings, why, why not? I was surprised by the magnitude of the effect when…
DetailsShots – Health Blog: NPR – Andrew Prince Traditional antidepressants like Prozac work on a group of chemical messengers in the brain called the serotonin system. Researchers once thought that a lack of serotonin was the cause of depression, and that these drugs worked simply by boosting serotonin levels. Recent research suggests a more…
DetailsClick here to read the NPR article.
The findings of the study presented below are in line with the data recorded in the study conducted by JBRF researchers: Sleep, Activity Patterns and Temperature Study. JBRF will continue to explore the role of thermoregulation in the biological basis of the Fear-of-Harm type of juvenile bipolar disorder. Lithium salt has been widely used in…
DetailsNIMH: Press Release • February 02, 2012 Gene Regulator in Brain’s Executive Hub Tracked Across Lifespan – NIH study For the first time, scientists have tracked the activity, across the lifespan, of an environmentally responsive regulatory mechanism that turns genes on and off in the brain’s executive hub. Among key findings of the study by National…
DetailsThe relationship between use of antidepressants and resource utilization among patients with manic or mixed bipolar disorder episodes: Findings from a managed care setting Self-Reported History of Manic/Hypomanic Switch Associated with Antidepressant Use: Data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) A Pilot Study of Antidepressant-Induced Mania in Pediatric Bipolar Disorder: Characteristics,…
Details
